Recent Finacing
Recent Raise
AnaCardio is a Swedish clinical-stage biopharmaceutical company, founded on Karolinska Institutet research, developing AC01, an oral ghrelin receptor agonist to enhance cardiac contractility for HFrEF.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
